[Gilles de la Tourette's syndrome. Current status of tic disease]. 1985

M Dugas

Two French physicians, J.M.G. Itard (1774-1838), then G. Gilles de la Tourette (1857-1904), have individualized a syndrome which has now been universally recognized for almost a century. Modern clinical studies conducted in the United States on a large number of patients have confirmed and completed Gilles de la Tourette's excellent description based on 9 cases. Interpreted at first as psychological, these "caricatures of natural acts" (J.M. Charcot) have given rise to numerous experimental studies in search of a possible imbalance of neurotransmitters. The inconstant or contradictory results obtained so far do not provide a coherent explanation. With its bizarre and disconcerting symptoms, the Gilles de la Tourette's syndrome compromises the social life of the patients throughout childhood and adulthood. Physicians should be able to diagnose the syndrome in order to help these patients, whose mental capacities remain unimpaired.

UI MeSH Term Description Entries
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D013981 Tic Disorders Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994) Post-Traumatic Tic Disorder,Tic Disorder, Chronic Motor or Vocal,Tic Disorder, Post-Traumatic,Tic Disorder, Transient,Tic Disorders, Vocal,Vocal Tic Disorders,Childhood Tic Disorders,Chronic Motor or Vocal Tic Disorder,Motor Tic Disorders,Motor or Vocal Tic Disorder, Chronic,Tic Disorders, Childhood,Tic Disorders, Motor,Transient Tic Disorder,Childhood Tic Disorder,Motor Tic Disorder,Post Traumatic Tic Disorder,Post-Traumatic Tic Disorders,Tic Disorder,Tic Disorder, Childhood,Tic Disorder, Motor,Tic Disorder, Post Traumatic,Tic Disorder, Vocal,Tic Disorders, Post-Traumatic,Tic Disorders, Transient,Transient Tic Disorders,Vocal Tic Disorder
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

M Dugas
January 1984, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
M Dugas
November 1997, Journal of the American Optometric Association,
M Dugas
January 1976, Language and speech,
M Dugas
January 1990, European journal of nuclear medicine,
M Dugas
April 1981, Meditsinskaia sestra,
M Dugas
April 1981, Texas medicine,
M Dugas
January 1974, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
M Dugas
March 2003, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
M Dugas
January 1984, Paediatrica Indonesiana,
M Dugas
October 1953, Edinburgh medical journal,
Copied contents to your clipboard!